Efficacy of Melatonin Administration in Reducing Headaches in Children with Migraines without Sleep Disorders Melatonin administration in Children with Migraine without Sleep Disorder.
Iranian Journal of Child Neurology,
Vol. 18 No. 3 (2024),
22 May 2024
,
Page 57-63
https://doi.org/10.22037/ijcn.v18i3.42197
Abstract
Objectives
Migraine is one of the common diseases of children, which can disrupt their quality of life. Some studies have shown the effect of melatonin in reducing migraine headaches. This study aims to investigate the effect of melatonin administration in reducing headaches in children with migraine without sleep disorders.
Materials & Methods
In this clinical trial study, fifty-five children aged five to 15 years with migraines who had no sleep disorder were enrolled. The control group (twenty-seven patients) was treated with propranolol tablets, and the intervention group (thirty patients) was treated with propranolol tablets plus melatonin tablets for three months. Patients were visited before, one month, and three months after the start of treatment, and their data was collected and recorded.
Results
The number of headache attacks decreased significantly in the intervention group compared to the control group three months after the treatment (P=0.006). The number of patients with a good response to treatment in the intervention group was significantly more than the control group (p=0.023). Parents’ satisfaction with the treatment in the intervention group was significantly higher than the control group (P=0.026). There was no significant difference in the intensity of disability caused by headaches after treatment in the two groups. No significant drug side effects were seen in any of the two groups.
Conclusion
Adding melatonin to the treatment of children with migraine without sleep disorders significantly reduces the frequency of headache attacks and increases satisfaction with the treatmen
- migraine, children, prevention, sleep disorder, melatonin
How to Cite
References
2. Jain S, Yuan H, Spare N, Silberstein SD. Erenumab in the treatment of migraine. Pain Manag. 2018 Nov 01; 8(6):415-426.
3. Al Khalili Y, Chopra P. Migraine Headache in Childhood. Stat Pearls [Internet]. Stat Pearls Publishing In: Treasure Island (FL); 2021 May 4.
4. Hoover L E. Migraines in Children: Recommendations for Acute and Preventive Treatment. Am Fam Physician. 2020 May 1; 101(9):569-571.
5. O'Brien HL, Kabbouche MA, Kacperski J, Hershey AD. Treatment of pediatric migraine. Curr Treat Options Neurol. 2015 Jan; 17(1):326.
6. Jain S, Silberstein SD. Invited Commentary on Preventive Anti-Migraine Therapy (PAMT). Curr Treat Options Neurol. 2019 Mar 14; 21(4):14.
7. Abbaskhanian A, Sadeghi HR, Erfani A, Rezai MS. Effective dose of topiramate in pediatric migraine prophylaxis. J Pediatr Neurosci. 2012 Sep;7(3):171-4
8. Lewis DW, Diamond S, Scott D, Jones V. Prophylactic treatment of pediatric migraine. Headache. 2004 Mar; 44(3):230-7.
9. Tonekaboni SH, Ghazavi A, Fayyazi A, Kajeh A, Taghdiri MM, AbdollahGorgi F, et al. Prophylaxis of Childhood Migraine: Topiramate Versus Propranolol. Iran J Child Neurol. 2013; 7(1):9-14
10. Lovati C, D’Amico D, Raimondi E, Mariani C, Bertora P. Sleep and headache: a bidirectional relationship. Expert review of neurotherapeutics. 2010; 10(1):105-17.
11. Engstrøm M, Hagen K, Bjørk MH, Stovner LJ, Gravdahl GB, Stjern M, et al. Sleep quality, arousal and pain thresholds in migraineurs: a blinded controlled polysomnographic study. The journal of headache and pain. 2013; 14(1):12.
12. Andress‐Rothrock D, King W, Rothrock J. An analysis of migraine triggers in a clinic‐based population. Headache: The Journal of Head and Face Pain. 2010; 50(8):1366-70.
13. Heng K, Wirrell E. Sleep disturbance in children with migraine. Journal of Child Neurology. 2006; 21(9):761-6.
14. Long R, Zhu Y, and Zhou S. Therapeutic role of melatonin in migraine prophylaxis, A systematic review. Medicine (Baltimore). 2019 Jan; 98(3): e14099.
15. Peres M, Zukerman E, da Cunha Tanuri F, Moreira F, Cipolla-Neto J. Melatonin, 3 mg, is effective for migraine prevention. Neurology. 2004; 63(4):757-.
16. Alstadhaug KB, Odeh F, Salvesen R, Bekkelund SI. Prophylaxis of migraine with melatonin: a randomized controlled trial. Neurology. 2010; 75(17):1527-32.
17. Liampas I, Siokas V, Brotis A, Vikelis M, Dardiotis E. Endogenous Melatonin Levels and Therapeutic Use of Exogenous Melatonin in Migraine: Systematic Review and Meta‐Analysis. Headache: The Journal of Head and Face Pain. 2020.
18. Teleanu R I. Treatment of Pediatric Migraine: a Review.Maedica (Bucur). 2016 Jun; 11(2): 136–143.
19. Papetti L, Ursitti F, Moavero R, Ferilli M, Sforza G, Tarantino S, et al. Prophylactic Treatment of Pediatric Migraine: Is There Anything New in the Last Decade? Front Neurol. 2019; 10: 771.
20. Gonçalves A L, Ferreira A M, Ribeiro R T, Zukerman E, Cipolla-Neto J, Prieto Peres M F. Randomized clinical trial comparing melatonin 3 mg, amitriptyline 25 mg and placebo for migraine prevention. BMJ Journal. 2016; 87(10).
21. Fallah R, Shoroki F F, Ferdosian F. Safety and efficacy of melatonin in pediatric migraine prophylaxis .Curr Drug Saf. 2015; 10(2):132-5.
22. Fallah R , Fazelishoroki F, Sekhavat L . A Randomized Clinical Trial Comparing the Efficacy of Melatonin and Amitriptyline in Migraine Prophylaxis of Children. Iran J Child Neurol. 2018 Winter;12(1):47-54.
23. Gelfand A A , Ross A C , Irwin S L , Greene K A , Qubty W F , Allen I E . Melatonin for Acute Treatment of Migraine in Children and Adolescents: A Pilot Randomized Trial .Headache. 2020 Sep; 60(8):1712-1721.
24. Tiseo C, Vacca A, Felbush A, Filimonova T, Gai A, Glazyrina T, et al. Migraine and sleep disorders: a systematic review. The Journal of Headache and Pain.2020, 21: 126.
25. Lin Y, Lin G, Lee J, Lee M, Tsai C, Hsu Y, et al. Associations Between Sleep Quality and Migraine Frequency. A Cross-Sectional Case-Control Study. Medicine (Baltimore). 2016 Apr; 95(17): e3554.
- Abstract Viewed: 730 times